Clinical Trial Update: Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial tested the combination of irinotecan, cetuximab, and everolimus in patients with metastatic colorectal cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Afinitor (everolimus) (everolimus)
• Camptosar (irinotecan) (irinotecan)
• Erbitux (cetuximab) (cetuximab)

Snippet

Sponsor: Herlev Hospital | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED